Develops a novel topical therapy for high-risk HPV infections and pre-cancerous cervical lesions, enabling non-surgical, at-home treatment.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Antiva Biosciences is developing a novel topical therapeutic for the treatment of high-risk human papillomavirus (HPV) infections and pre-cancerous cervical lesions in women. The company aims to provide a simple, non-surgical treatment option that can be used at home, improving health outcomes and access to care worldwide.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Antiva Biosciences Management Team
Investors
Adjuvant Capital
Alexandria Venture Investments
Avestria Ventures
Brace Pharma Capital
Canaan Partners
Gaingels Syndicate
Google Ventures
HBM Healthcare Investments AG
Hillhouse Capital Group
Lumira Ventures
NS Investment
Osage University Partners
Sirona Capital Pty Ltd
Sofinnova Ventures Inc
Antiva Biosciences Valuations & Financials
View real-time NPM data on Antiva Biosciences stock including daily Antiva Biosciences stock price estimates, valuation history, and historical share price information. Access Antiva Biosciences financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Antiva Biosciences pricing across six independent market signals. Looking for private company due diligence data sources on Antiva Biosciences? Get in touch to learn more.
Similar Companies
like Antiva Biosciences
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Clearing
Healthcare & Life Sciences
Digital healthcare platform providing comprehensive opioid-free treatment solutions for chronic pain management.
Premise Data
Deploys a decentralized mobile platform to aggregate local on-the-ground data and generate real-time geospatial analytics.
iCreditWorks
FinTech
Mobile fintech platform providing instant dental procedure financing through a streamlined application process and loan management system.
Logiwa
Cloud-based fulfillment software streamlining high-volume DTC, wholesale, and 3PL warehouse and order operations with seamless integrations.
Arrive.tech
AI & Machine Learning
Develops autonomous last-mile delivery solutions with smart, climate-controlled mailboxes that enable secure package delivery by robots and drones.
CYRISMA
Delivers an all-in-one, multi-tenant risk management platform enabling MSPs to efficiently manage cybersecurity for multiple clients.
Erebor
FinTech
Provides digital banking and financial infrastructure that supports crypto and tech-focused businesses with modern asset and payment services.
Cruz Foam
Creates sustainable, bio-based foam packaging that replaces petroleum-based foams and naturally disintegrates after use.
FAQ
We have answers
Antiva Biosciences stock does not trade on public stock exchanges. Antiva Biosciences stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Antiva Biosciences stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Antiva Biosciences Stock does not trade on public stock exchanges. In order to sell Antiva Biosciences shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Antiva Biosciences does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Antiva Biosciences share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Antiva Biosciences stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Antiva Biosciences stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Antiva Biosciences stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Antiva Biosciences is a private company and has not had an IPO. There is currently no Antiva Biosciences IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Antiva Biosciences IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
